From: microRNA-21 expressions impact on liver fibrosis in biliary atresia patients
miRNA-21 | PTEN | α-SMA | |
---|---|---|---|
Age at Kasai operation of ≥ 90 days (n = 9) | − 3.6 ± 4.4 | 0.01 ± 0.9 | 12.7 ± 3.6 |
Age of Kasai operation of < 90 days (n = 7) | − 2.5 ± 3.2 | 0.2 ± 1.9 | 13.8 ± 2.5 |
ΔΔCT (95% CI) | − 1.1 (− 4.4 to 2.2) | − 0.2 (− 1.7 to 1.3) | − 1.2 (− 3.9 to 1.6) |
Fold change (2−ΔΔCT) | 2.1 | 1.1 | 2.3 |
p-value | 0.65 | 0.45 | 0.39 |
Cirrhosis (ΔCT ± SD) (n = 4) | − 0.8 ± 2.2 | 0.4 ± 2.3 | 12.4 ± 1.4 |
Non-cirrhosis (ΔCT ± SD) (n = 12) | − 5.3 ± 3.9 | − 0.03 ± 0.9 | 13.9 ± 4.3 |
ΔΔCT (95% CI) | 4.5 (1.8–7.2) | 0.4 (− 1.2 to 2.0) | − 1.5 (− 4.2 to 1.2) |
Fold change (2−ΔΔCT) | 25 | 1.3 | 2.8 |
p-value | 0.004* | 0.76 | 0.44 |
Died (ΔCT ± SD) (n = 9) | − 2.1 ± 4.1 | 0.3 ± 1.6 | 13.4 ± 3.2 |
Survived (ΔCT ± SD) (n = 7) | − 4.1 ± 3.4 | − 0.2 ± 1.0 | 12.5 ± 3.2 |
ΔΔCT (95% CI) | 1.9 (− 1.3 to 5.2) | 0.5 (− 1.0 to 2.0) | 0.9 (− 1.9 to 3.6) |
Fold change (2−ΔΔCT) | 3.8 | 1.5 | 1.8 |
p-value | 0.22 | 0.35 | 0.52 |